1 |
|
EPH-Ephrin signaling
|
143 |
1.131 |
Genes names |
|
Pathways |
- Cytoskeleton remodeling Fibronectin-binding integrins in cell motility
|
|
2 |
|
Cell surface interactions at the vascular wall
|
137 |
1.131 |
Genes names |
|
Pathways |
- Fibronectin matrix formation
|
|
3 |
|
Signaling by Receptor Tyrosine Kinases
|
524 |
0.802 |
Genes names |
- Fibronectin Leucine Rich Transmembrane Protein 1
- Fibronectin Leucine Rich Transmembrane Protein 2
- Fibronectin Leucine Rich Transmembrane Protein 3
- Fibronectin 1
|
|
4 |
|
Protein-protein interactions at synapses
|
86 |
0.802 |
Genes names |
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 1
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 2
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 3
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 4
|
|
5 |
|
Unblocking of NMDA receptors, glutamate binding and activation
|
40 |
0.802 |
Genes names |
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 1
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 2
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 3
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 4
|
|
6 |
|
Signal Transduction
|
2590 |
0.802 |
Genes names |
- Fibronectin Leucine Rich Transmembrane Protein 1
- Fibronectin Leucine Rich Transmembrane Protein 2
- Fibronectin Leucine Rich Transmembrane Protein 3
- Fibronectin 1
|
|
7 |
|
Transmission across Chemical Synapses
|
410 |
0.802 |
Genes names |
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 1
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 2
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 3
- Leucine Rich Repeat And Fibronectin Type III Domain Containing 4
|
|
8 |
|
Downstream signaling of activated FGFR2
|
51 |
0.695 |
Genes names |
- Fibronectin Leucine Rich Transmembrane Protein 1
- Fibronectin Leucine Rich Transmembrane Protein 2
- Fibronectin Leucine Rich Transmembrane Protein 3
|
|
9 |
|
Negative regulation of FGFR1 signaling
|
58 |
0.695 |
Genes names |
- Fibronectin Leucine Rich Transmembrane Protein 1
- Fibronectin Leucine Rich Transmembrane Protein 2
- Fibronectin Leucine Rich Transmembrane Protein 3
|
|
10 |
|
Signaling by FGFR2
|
87 |
0.695 |
Genes names |
- Fibronectin Leucine Rich Transmembrane Protein 1
- Fibronectin Leucine Rich Transmembrane Protein 2
- Fibronectin Leucine Rich Transmembrane Protein 3
|
|
11 |
|
miR-509-3p alteration of YAP1/ECM axis
|
17 |
0.401 |
|
12 |
|
Small cell lung cancer
|
96 |
0.401 |
|
13 |
|
Non-integrin membrane-ECM interactions
|
82 |
0.401 |
|
14 |
|
Cytoskeleton remodeling Regulation of actin cytoskeleton by Rho GTPases
|
187 |
0.401 |
|
15 |
|
Interactions between LOXL4 and oxidative stress pathway
|
18 |
0.401 |
|
16 |
|
Blood-Brain Barrier and Immune Cell Transmigration: Overview
|
71 |
0.401 |
|
17 |
|
Alpha4 beta1 integrin signaling events
|
34 |
0.401 |
|
18 |
|
Physico-chemical features and toxicity-associated pathways
|
65 |
0.401 |
|
19 |
|
Mammary gland development pathway - Puberty (Stage 2 of 4)
|
13 |
0.401 |
|
20 |
|
Mesenchymal Stem Cells and Lineage-specific Markers
|
95 |
0.401 |
|
21 |
|
CCL18 signaling pathway
|
96 |
0.401 |
|
22 |
|
Syndecan-4-mediated signaling events
|
31 |
0.401 |
|
23 |
|
Syndecan-2-mediated signaling events
|
34 |
0.401 |
|
24 |
|
VEGFR3 signaling in lymphatic endothelium
|
24 |
0.401 |
|
25 |
|
3q29 copy number variation syndrome
|
62 |
0.401 |
Genes names |
- Fibronectin Type III Domain Containing 8
|
|
26 |
|
PI3K-Akt signaling pathway
|
390 |
0.401 |
|
27 |
|
ECM proteoglycans
|
121 |
0.401 |
|
28 |
|
Oncogenic MAPK signaling
|
84 |
0.401 |
|
29 |
|
Development Angiotensin activation of ERK
|
225 |
0.401 |
|
30 |
|
ERK Signaling
|
1185 |
0.401 |
|
31 |
|
Regulation of actin cytoskeleton
|
151 |
0.401 |
|
32 |
|
Cell adhesion_Plasmin signaling
|
49 |
0.401 |
|
33 |
|
Inflammatory response pathway
|
33 |
0.401 |
|
34 |
|
miRNA targets in ECM and membrane receptors
|
38 |
0.401 |
|
35 |
|
VEGF Signaling Pathway
|
93 |
0.401 |
|
36 |
|
VEGF Pathway (Qiagen)
|
122 |
0.401 |
|
37 |
|
MET promotes cell motility
|
118 |
0.401 |
|
38 |
|
Immune response IL-23 signaling pathway
|
160 |
0.401 |
|
39 |
|
Integrin family cell surface interactions
|
95 |
0.401 |
|
40 |
|
Articular Cartilage Extracellular Matrix
|
36 |
0.401 |
|
41 |
|
17q12 copy number variation syndrome
|
99 |
0.401 |
Genes names |
- Fibronectin Type III Domain Containing 8
|
|
42 |
|
Immune response_Role of integrins in NK cells cytotoxicity
|
44 |
0.401 |
|
43 |
|
Integrins in angiogenesis
|
57 |
0.401 |
|
44 |
|
Regulation of expression of SLITs and ROBOs
|
462 |
0.401 |
Genes names |
- Fibronectin Leucine Rich Transmembrane Protein 3
|
|
45 |
|
Cell adhesion_ECM remodeling
|
61 |
0.401 |
|
46 |
|
Metabolism of proteins
|
1970 |
0.401 |
|
47 |
|
TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition
|
14 |
0.401 |
|
48 |
|
Epithelial to mesenchymal transition in colorectal cancer
|
161 |
0.401 |
|
49 |
|
Response to elevated platelet cytosolic Ca2+
|
621 |
0.401 |
|
50 |
|
Elastic fibre formation
|
44 |
0.401 |
|
51 |
|
Integrin Pathway
|
570 |
0.401 |
|
52 |
|
Cytokine Signaling in Immune system
|
732 |
0.401 |
|
53 |
|
Bacterial infections in CF airways
|
97 |
0.401 |
|
54 |
|
Interleukin-4 and Interleukin-13 signaling
|
108 |
0.401 |
|
55 |
|
GPCR downstream signalling
|
710 |
0.401 |
|
56 |
|
VEGFA-VEGFR2 signaling
|
154 |
0.401 |
|
57 |
|
Phospholipase-C Pathway
|
503 |
0.401 |
|
58 |
|
Signaling downstream of RAS mutants
|
83 |
0.401 |
|
59 |
|
Nervous system development
|
1168 |
0.401 |
Genes names |
- Fibronectin Leucine Rich Transmembrane Protein 3
|
|
60 |
|
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling
|
39 |
0.401 |
|
61 |
|
Alpha9 beta1 integrin signaling events
|
25 |
0.401 |
|
62 |
|
Development Endothelin-1/EDNRA transactivation of EGFR
|
115 |
0.401 |
|
63 |
|
Beta5 beta6 beta7 and beta8 integrin cell surface interactions
|
17 |
0.401 |
|
64 |
|
Urotensin-II-mediated signaling pathway
|
45 |
0.401 |
|
65 |
|
Overview of nanoparticle effects
|
19 |
0.401 |
|
66 |
|
Senescence and autophagy in cancer
|
105 |
0.401 |
|
67 |
|
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
|
125 |
0.401 |
|
68 |
|
Focal adhesion
|
197 |
0.401 |
|
69 |
|
Malignant pleural mesothelioma
|
409 |
0.401 |
|
70 |
|
RAF/MAP kinase cascade
|
571 |
0.401 |
|
71 |
|
Integrin signaling
|
39 |
0.401 |
|
72 |
|
Infectious disease
|
1747 |
0.401 |
|
73 |
|
Innate Immune System
|
2025 |
0.401 |
|
74 |
|
Extracellular matrix organization
|
300 |
0.401 |
|
75 |
|
Signaling by ALK in cancer
|
55 |
0.401 |
|
76 |
|
G alpha (s) signalling events
|
158 |
0.401 |
|
77 |
|
Beta3 integrin cell surface interactions
|
39 |
0.401 |
|
78 |
|
ADORA2B mediated anti-inflammatory cytokines production
|
419 |
0.401 |
|
79 |
|
1p36 copy number variation syndrome
|
88 |
0.401 |
Genes names |
- Fibronectin Type III Domain Containing 10
|
|